Rubio-Pérez, L.; Frago, S.; Compte, M.; Navarro, R.; Harwood, S.L.; Lázaro-Gorines, R.; Gómez-Rosel, M.; Hangiu, O.; Silva-Pilipich, N.; Vanrell, L.;
et al. Characterization of a Trispecific PD-L1 Blocking Antibody That Exhibits EGFR-Conditional 4-1BB Agonist Activity. Antibodies 2024, 13, 34.
https://doi.org/10.3390/antib13020034
AMA Style
Rubio-Pérez L, Frago S, Compte M, Navarro R, Harwood SL, Lázaro-Gorines R, Gómez-Rosel M, Hangiu O, Silva-Pilipich N, Vanrell L,
et al. Characterization of a Trispecific PD-L1 Blocking Antibody That Exhibits EGFR-Conditional 4-1BB Agonist Activity. Antibodies. 2024; 13(2):34.
https://doi.org/10.3390/antib13020034
Chicago/Turabian Style
Rubio-Pérez, Laura, Susana Frago, Marta Compte, Rocío Navarro, Seandean L. Harwood, Rodrigo Lázaro-Gorines, Marina Gómez-Rosel, Oana Hangiu, Noelia Silva-Pilipich, Lucía Vanrell,
and et al. 2024. "Characterization of a Trispecific PD-L1 Blocking Antibody That Exhibits EGFR-Conditional 4-1BB Agonist Activity" Antibodies 13, no. 2: 34.
https://doi.org/10.3390/antib13020034
APA Style
Rubio-Pérez, L., Frago, S., Compte, M., Navarro, R., Harwood, S. L., Lázaro-Gorines, R., Gómez-Rosel, M., Hangiu, O., Silva-Pilipich, N., Vanrell, L., Smerdou, C., & Álvarez-Vallina, L.
(2024). Characterization of a Trispecific PD-L1 Blocking Antibody That Exhibits EGFR-Conditional 4-1BB Agonist Activity. Antibodies, 13(2), 34.
https://doi.org/10.3390/antib13020034